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Polymyxin B containing polyion 
complex (PIC) nanoparticles: 
Improving the antimicrobial 
activity by tailoring the degree 
of polymerisation of the inert 
component
Ignacio Insua  1,3, Laimdota Zizmare1,3, Anna F. A. Peacock1, Anne Marie Krachler2,3,4 & 
Francisco Fernandez-Trillo  1,3
Here, we describe the preparation and characterisation of polyion complex (PIC) nanoparticles 
containing last resort antimicrobial polymyxin B (Pol-B). PIC nanoparticles were prepared with 
poly(styrene sulphonate) (PSS) as an inert component, across a range of degrees of polymerisation 
to evaluate the effect that multivalency of this electrolyte has on the stability and antimicrobial 
activity of these nanoparticles. Our results demonstrate that while nanoparticles prepared with longer 
polyelectrolytes are more stable under simulated physiological conditions, those prepared with shorter 
polyelectrolytes have a higher antimicrobial activity. Tailoring the degree of polymerisation and the 
ratio of the components we have been able to identify a formulation that shows a sustained inhibitory 
effect on the growth of P. aeruginosa and can reduce the number of viable colonies of this pathogen 
over 10,000 times more effectively than our previously reported formulation.
Polyion complex (PIC) particles, also known as polyelectrolyte complexes (PECs) or interpolyelectrolyte com-
plexes (IPECs), are soft colloids formed by the spontaneous aggregation of oppositely charged polyelectrolytes in 
aqueous media1–3. Due to their straightforward preparation and versatility, PIC particles are particularly suited 
for the delivery of charged (bio)molecules (e.g. nucleic acids and proteins), which are prevalent in nature3–5. This 
way, delivery vehicles can be formulated without the need to introduce chemical modifications to these (bio)
molecules and as a result, the biological activity of these therapeutics should be maintained upon release. PIC 
particle formation and stability are dominated by entropic effects6 making them ideal for the delivery of “large” 
and densely charged macromolecules such as nucleic acids3, 7, 8. More challenging is the use of PIC particles for the 
delivery of proteins9, 10, peptides11 or small molecules3, which often lack the required charge density to form stable 
PIC particles. However, many of the characteristics of PIC particles makes them ideally suited for the delivery of 
antimicrobial peptides, which are small cationic peptides that have been harnessed as last-resort antimicrobials 
or as alternatives to current antibiotics12–14. The cationic residues in antimicrobial peptides can be shielded within 
PIC particles15–18, thus minimising the toxicity towards the host associated with the cationic and amphiphilic 
nature of antimicrobial peptides12–14, 19, 20. With the increasing concern of antimicrobial resistance, new ways of 
employing antimicrobials are highly desired, either through repurposing “old” antibiotics, or finding better ways 
of using current antimicrobials21, 22. In this regard, encapsulation of antimicrobials in polymeric nanomaterials 
can offer several advantages, including decreasing toxicity, improving bioavailability, increasing circulation time, 
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or improving penetration in infected tissues23–25. In applications such as wound healing, a sustained release of the 
antimicrobial may be desirable, to maintain a therapeutic level of the antimicrobial throughout the treatment.
In our laboratories, we have recently developed PIC nanoparticles loaded with the clinically approved antibi-
otic polymyxin B (Pol-B)26–30 by complexation with FDA approved poly(styrene sulphonate) (PSS)15. Both Pol-B 
and PSS are strong polyelectrolytes (pKaH 9–1031 and pKa ∼ −2.532 respectively) and fully charged at neutral pH, 
making them ideal components for the formulation of PIC nanoparticles. These Pol-B containing nanoparti-
cles displayed a moderate antimicrobial effect against Pseudomonas aeruginosa, an opportunistic Gram-negative 
bacterium, for which Pol-B is currently used as a last resort antimicrobial. Based on the correlation between the 
stability of PIC particles and the net charge of their consisting polyelectrolytes, the formulation of Pol-B with 
shorter polyelectrolytes can potentially result in more permeable PIC nanoparticles with stronger antimicrobial 
properties.
In this communication, we describe how the antimicrobial activity of these Pol-B containing PIC nanopar-
ticles has been significantly improved by tailoring the molecular weight of the inert component, PSS. First, we 
investigate the effect that reducing the degree of polymerisation of PSS (i.e. molecular weight) has on the stability 
of the formed nanoparticles under simulated physiological conditions and in growth medium. Then, we evaluate 
the antimicrobial activity against P. aeruginosa of the resulting Pol-B containing PIC nanoparticles. Our results 
indicate that nanoparticles prepared with shorter PSS are less stable under simulated physiological conditions but 
result in significantly higher antimicrobial activities, and leads to the identification of a formulation that shows a 
sustained inhibitory effect on the growth of P. aeruginosa and that reduces the number of viable colonies of this 
pathogen more effectively than our previously reported formulation.
Experimental
Materials. Polymyxin B sulphate (Pol-B) was purchased from Alfa Aesar®. Sodium poly(styrene sulphonate) 
(PSS) of 32, 17 and 10 kDa average Mw (GPC standards), 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid 
(HEPES), phosphotungstic acid hydrate, agar and Luria Bertani (LB) broth (Miller) were bought from Sigma-
Aldrich Ltd. Nylon 0.45 µm syringe filters were purchased from Camlab Ltd. Carbon-coated nickel TEM grids 
(200 mesh) were purchased from Agar Scientific Ltd. Dulbecco’s phosphate buffered saline (DPBS), 9.5 mM in 
phosphate and without Ca2+ and Mg2+, was bought from Lonza.
Instrumentation. Dynamic light scattering (DLS) and ζ-potential measurements were carried out in 
a Zetasizer Nano ZSP (Malvern Instruments Ltd.) stabilised at 37 °C. DLS was read at 173° (backscattering) for 
60 seconds in triplicate and ζ-potentials were recorded 30 times at 140 V. Transmission Electron Microscopy (TEM) 
images of PIC nanoparticles were acquired on a JEM-1200EX (JEOL USA Inc.). PIC nanoparticle size was measured 
from TEM micrographs using ImageJ software (1.48 v) and measuring each nanoparticle twice: both in their longest 
and shortest diameters. A Loctite® LED flood array (Henkel Ltd.) operating at 405 nm was used to sterilise the sam-
ples studied in the bacterial growth experiment. A FLUOstar Omega (BMG Labtech GmbH.) microplate reader was 
used to incubate and measure the optical density at 600 nm (OD600) in the bacterial growth experiments. Pictures of 
agar plates were taken on a ChemiDocTM MP imaging system (Bio-Rad laboratories Inc.).
Preparation of PIC nanoparticles. PIC nanoparticles from Pol-B and PSS were prepared following the 
protocol previously described by our group15, 33. The different formulations of PIC nanoparticles are defined by 
their [n+/n−] ratio, which represents the proportion of ammonium groups in Pol-B over acidic groups in PSS. 
As a representative example, for the preparation of PIC nanoparticles at 0.5 [n+/n−] ratio, solutions of Pol-B 
(0.25 mM) and PSS (2.5 mM in monomer units) were prepared separately in 5 mM HEPES buffer at pH 7.4. Then, 
both stock solutions were filtered through 0.45 µm nylon syringe filters and mixed in equal amounts drop-wise 
under stirring. PIC nanoparticles at other [n+/n−] ratios were obtained by changing the concentration of the 
Pol-B stock solution and mixing with 2.5 mM PSS following the same protocol. After 24 h, the polyion mixtures 
were characterised by DLS and ζ-potential without prior dilution nor filtration (Table S1†).
TEM imaging of PIC nanoparticles. For TEM analysis, 5 µL of a suspension of PIC nanoparticles were 
deposited on the surface of the TEM grid and it was left to dry at room temperature covered from dust. Once 
dried, 5 µL of a 1 mg·mL−1 solution of phosphotungstic acid in water were deposited on the grid to stain the nan-
oparticles for a minute, after which the excess staining solution was removed. Finally, the grid was dried as before.
Stability of PIC nanoparticles in simulated physiological conditions. To a sample of PIC nanopar-
ticles (1 mL), prepared as described above, 182 μL of a 1 M solution of NaCl in water was added and the mixture 
was incubated at 37 °C to obtain physiological osmotic pressure and temperature. Every hour, the sample was 
analysed by DLS as described above.
Pol-B diffusion during dialysis. 2.5 mL (or 1.2 mL for Amicon Ultra centrifugal filter units) of a 175 μM 
solutions of Pol-B in 5 mM HEPES buffer pH 7.4 were transferred into pre-conditioned dialysis devices 
(Float-a-Lyzer® G2 or Amicon), and were dialysed against 15 mL (or 8 mL for Amicon) of DPBS at 37 °C under 
stirring. 500 μL of dialysate were taken at different time points and replaced with fresh DPBS. The dialysate sam-
ples were analysed by HPLC using an adaptation of the method previously reported by Orwa et al.34, using a 
50:23:22:5 mixture of 50 mM Na2SO4 in H2O: H2O: AcCN: 5% (v/v) dilution of 85% (m/m) H3PO4 in H2O run-
ning at 1 mL/min. 3 replicates were studied under the same conditions. At every time point, the area under the 
peak of Pol-B found in each dialysate sample was normalised to the area found in a non-dialysed solution of Pol-B 
prepared at the same concentration and diluted with 15 mL of DPBS (100% release).
www.nature.com/scientificreports/
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Antimicrobial evaluation of PIC nanoparticles: Growth curves. 100 μL aliquots of P. aeruginosa 
PAO1V35 cultures in LB broth (OD600 = 0.2) were loaded in the designated positions of a 96-well microplate. 
These bacterial cultures were mixed with 100 μL of PIC nanoparticles or free Pol-B in 5 mM HEPES buffer pH 7.4 
to compare the antimicrobial activity of free and complexed (within PIC nanoparticles) Pol-B at the same concen-
tration. Alternatively, these bacterial cultures were mixed with 100 μL of 5 mM HEPES buffer pH 7.4 as positive 
growth control or 1.25 mM (in monomer units) PSS in 5 mM HEPES buffer pH 7.4. to evaluate the effect of the 
polymers alone. Finally, 200 μL of a 1:1 mixture of the LB broth and 5 mM HEPES buffer pH 7.4 were also loaded 
in the microplate to confirm the sterility of the medium. All samples were prepared in triplicate, with mean values 
and standard deviations reported. The microplate was incubated at 37 °C and orbital shaking, and the OD600 was 
monitored every 30 min for 24 h. The samples of PIC nanoparticles, free Pol-B, PSS and 5 mM HEPES buffer 7.4 
were sterilised prior to this experiment by exposure to blue light (405 nm) for 2 h at a distance of 15 cm from the 
light source.
Antimicrobial evaluation of PIC nanoparticles: CFU counting. After 24 h, 10 µL of the samples from 
the ‘growth curve’ experiment (see above) were spotted in triplicate on LB agar plates in serial dilution, from 
undiluted to 102, 104 and 106-fold dilutions. These agar plates were then incubated at 37 °C. After 18 h of incu-
bation, the agar plates were photographed and bacterial concentrations in CFU·mL−1 were calculated from the 
highest dilution that showed individual colonies.
Results and Discussion
We have recently reported the preparation of PIC nanoparticles via self-assembly of the cationic antibiotic 
polymyxin B (Pol-B) and the polyanion poly(styrene sulphonate) (PSS)15. These nanoparticles displayed a 
formulation-dependent antimicrobial effect against P. aeruginosa, and can be an alternative delivery vehicle to 
the conventional use of antibiotics. Although the complexation of Pol-B is challenging due to its low net charge or 
multivalency (Fig. 1)36, this antibiotic was successfully assembled into PIC nanoparticles using a very high molec-
ular weight PSS (70 kDa). The low multivalency of pentacationic Pol-B was compensated with PSS chains bearing 
ca. 340 charges on average, forming a highly multivalent network of electrostatic cross-links that stabilised these 
PIC nanoparticles. However, these nanoparticles showed moderate antimicrobial activity and our results sug-
gested that the antimicrobial activity of the nanoparticles was related to the stability of the nanoparticles in the 
assay growth medium.
Since the stability of PIC particles in solution strongly depends on the multivalency of their constitutive pol-
yelectrolytes3, we propose here that the complexation of Pol-B with shorter PSS would lead to less stable pol-
yelectrolyte complexes with potentially faster Pol-B release profiles and higher antimicrobial activities. To test 
this hypothesis, we investigated the assembly of PIC nanoparticles from Pol-B and PSS with average molecular 
weights below 70 kDa. We selected commercial PSS sources of 30 and 15 kDa to test polymers with approximately 
half and a fourth of the Mw previously reported. Moreover, the shortest commercially available PSS (10 kDa) was 
also tested (Table 1).
Pol-B was therefore mixed with each PSS in ten different proportions (i.e. charge ratios), denoted as [n+/n−], 
indicating the number of ammonium groups in Pol-B divided by the number of sulphonates in PSS present in 
each nanoparticle formulation. The evaluation of a range of charge ratios is critical because this parameter not 
only dictates the dose of antibiotic loaded inside these nanoparticles, but it can also affect their stability in solu-
tion3. Nanoparticles were used as prepared without further purification, in a similar fashion to those previously 
reported using 70 kDa PSS15. In the absence of additional steps to stabilise the particles (e.g. cross-linking), PIC 
particles are always present as a mixture with the individual components. Any attempt to remove loosely bound 
drug will result in the destabilisation of the system, particularly for PIC particles like the ones reported here that 
Figure 1. Schematic representation of the formation of PIC nanoparticles by self-assembly of cationic 
polymyxin B with poly(styrene sulphonate) (PSS) and effect of the change in multivalency.
www.nature.com/scientificreports/
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employ polyelectrolytes with low multivalency. We anticipate that, upon application, any Pol-B that is free or 
loosely bound to the particles would have an immediate effect on P. aeruginosa, while the nanoparticles would 
act as a reservoir of the drug, maintaining therapeutic levels of the antimicrobial. The range of [n+/n−] ratios 
explored here was selected from our previous observations with a 70 kDa PSS and Pol-B, which formed unsta-
ble complexes that flocculated at values of [n+/n−] ≥ 1 due to the complete neutralisation of the PSS chains by 
Pol-B15. Thus, we decided to explore [n+/n−] ratios between 1.0 and 0.1 and the resulting nanoparticle formula-
tions were characterised by DLS and ζ-potential (Fig. 2, Table S1†). Colloidal particles were obtained for most of 
these formulations even when as few as 0.1 equivalents of Pol-B were employed. As observed for other polyelec-
trolytes37, 38, we were not able to form PIC nanoparticles with any of the PSS tested at [n+/n−] ratios around equi-
molar range (i.e. 1.0, 0.9, and even 0.8 for the highest Mw PSS tested here, PSSH), which led to unstable aggregates 
that flocculated due to charge neutralisation (Fig. 2).
All nanoparticles prepared from PSS showed almost identical hydrodynamic diameters (DH) and ζ-potentials 
regardless of the DP of the polymer, with average values of 192 nm (±4%)39 in DH and −49.6 mV (±6%)39 in 
charge (Fig. 2). These values were in agreement with those previously reported for 70 kDa PSS15. Representative 
formulations were analysed using TEM to assess whether such loose complexes would still retain morphological 
features of a nanoparticle. Spherical aggregates were found by TEM for nanoparticles prepared with the longest 
PSS investigated at a 0.4 [n+/n−] ratio (Fig. 3). The size of these PIC nanoparticles when analysed by TEM 
(267 ± 72 nm, n = 90) was bigger than their DH in solution (119 nm ± 28%), suggesting that they could be collaps-
ing upon drying during sample preparation for TEM analysis40. TEM imaging of nanoparticles prepared at the 
same ratio for the shortest PSS evaluated did not reveal any clear morphology (Fig. S1†), suggesting that these 
nanoparticles were not stable during the TEM sample preparation.
We then focused on assessing the stability of the prepared PIC nanoparticles in physiological conditions. Since 
small electrolytes in solution can shield the ionic networks that cross-link PIC nanoparticles, it is expected that 
the salts present in biological fluids can compromise the integrity of these nanoparticles. In order to test their 
stability, all the formulations described above were incubated in 154 mM NaCl at 37 °C and pH 7.4 to simulate 
physiological conditions, and DLS was monitored over time. For clarity purposes, only the DLS data for PIC 
Codea Mpb Mwb DPc Đb
PSSH 29,500 29,100 141 <1.2
PSSM 15,800 14,900 72 <1.2
PSSL 10,200 10,600 51 <1.2
Table 1. Polyanions investigated in this work. aPSS subindexes stand for high (H), medium (M) and low (L) DP. 
bData provided by the manufacturer. cDegree of polymerization based on the Mw.
Figure 2. Hydrodynamic diameter (DH, ⦁) and ζ-potential (○) of PIC nanoparticles prepared at different [n+/
n−] ratios from Pol-B and PSSH (A), PSSM (B), and PSSL (C). Blank spaces indicate unstable formulations that 
flocculated. Each value represents the mean diameter or charge of the only size or charge population fitted by 
the software ± its standard deviation.
Figure 3. TEM micrographs of PIC nanoparticles prepared from Pol-B and PSSH at a 0.4 [n+/n−] ratio (A–C) 
and the size distribution of these nanoparticles found by TEM (D). Scale bars from left to right: 0.5 (A), 0.5 (B) 
and 0.2 μm (C).
www.nature.com/scientificreports/
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nanoparticles prepared at 0.7 and 0.4 [n+/n−] ratios will be discussed next, representing high and low Pol-B 
loading respectively. The DLS data for all the other nanoparticle formulations evaluated can be found in Fig. S2–
S4†, and overall showed very similar profiles to either 0.7 or 0.4 [n+/n−] ratios, depending on the value to which 
they were closer. Also, formulations at [n+/n−] ratios of 0.1 showed extremely poor stability to salt as expected 
from their low Pol-B loading and hence weak electrostatic cross-linking of the complex. All PIC nanoparticles 
swelled in the presence of 154 mM NaCl, due to an increase in electrostatic repulsion as small electrolytes shield 
the electrostatic attraction between the oppositely charged components of these nanomaterials. This process can 
be assisted by the association of nanoparticles as they become colloidally unstable, resulting in an overall increase 
in size41, 42. For the reported nanoparticles in this manuscript, this behaviour was strongly influenced by the DP 
of the polymer. Formulations containing the longest polyelectrolyte, PSSH, showed almost no changes in their 
autocorrelation functions (ACFs) and size distributions by DLS, with only a 2-fold increase in size after 4 hours 
(Fig. 4). However, PSSM and PSSL experienced more pronounced swelling, increasing 7 and 20 times their initial 
hydrodynamic diameters after 4 hours, respectively. Whereas PSSH did not show any difference between [n+/
n−] ratios, probably due to the strong complexation of Pol-B by this polymer, PSSM and PSSL formed more stable 
complexes at a 0.4 [n+/n−] ratio than at 0.7. This lack of stability was evident from the loss of the characteristic 
sigmoidal profile in the ACF curves of these nanoparticles (e.g. Fig. 4B vs E), which can be attributed to these 
nanoparticles breaking down into amorphous debris, as suggested by the smaller-size population found in their 
intensity plots after 4 hours (Fig. 4B,C).
Figure 4. DLS autocorrelation function (ACF) curves and representative size-intensity plots (inset) of PIC 
nanoparticles prepared from PSSH (A,D), PSSM (B,E) and PSSL (C,F) at [n+/n−] ratios of 0.7 (A–C) and 0.4 
(D–E) in the absence (control) and presence of 154 mM NaCl (1–4 hours).
Figure 5. Changes in OD600 for 1:1 LB:HEPES growth medium in the absence (A, ○) and presence of PIC 
nanoparticles prepared at a 0.7 (A) and 0.4 (B) [n+/n−] ratio. Error bars represent the standard deviation, n = 3.
www.nature.com/scientificreports/
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Having characterised the stability under simulated physiological conditions of the different formulations pre-
pared, we then evaluated the swelling and stability of these particles in the growth medium used for the antimi-
crobial assays. This behaviour can be inferred by measuring the changes to the optical density at 600 nm (OD600) 
of particle suspensions in growth medium, as demonstrated in our previous work15. Experiments were focused 
on particles prepared at 0.7 and 0.4 [n+/n−] ratios, because the stability under physiological conditions demon-
strated that these formulations were representative examples of the whole series. All nanoparticle formulations 
increased the OD600 when incubated in biological medium, and this effect was dependent on the Pol-B content 
and the degree of polymerisation of PSS (Fig. 5). Overall, formulations prepared at a 0.7 [n+/n−] ratio increased 
the turbidity of the medium much more dramatically than their analogues at 0.4, while decreasing the size of the 
polyelectrolyte resulted in formulations that increased the optical density of the medium faster and to a greater 
extent (e.g. OD600 up to 0.7 in the presence of nanoparticles prepared with PSSL at a 0.7 [n+/n−] ratio). For 
instance, nanoparticles prepared with PSSH at a 0.7 [n+/n−] ratio showed a steady increase in OD600, suggesting 
that these nanoparticles were swelling or aggregating, but remained stable under assay conditions. On the other 
hand, particles prepared with the smaller polyelectrolytes, PSSM and PSSL, showed a bigger increase in OD600, 
Figure 6. Change in optical density at 600 nm (OD600) for P. aeruginosa cultures in the absence (⦁) and 
presence of PSS containing PIC nanoparticles prepared at 0.7 (A) or 0.4 (B) [n+/n−] ratios. Error bars 
represent the standard deviation, n = 3. (C) Representative relative changes in OD600 from P. aeruginosa cultures 
in the absence (+Control) and presence of PSS containing PIC nanoparticles prepared at 0.7 or 0.4 [n+/n−] 
ratios, indicated in brackets. **p < 0.01, ‘N/S’ = not significant (two-way ANOVA, Tukey test, CI = 95%). Error 
bars represent the standard deviation, n = 3.
www.nature.com/scientificreports/
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with nanoparticles prepared with PSSL giving an initial OD600 that was more than 3.5x bigger than that of the 
growth medium (Fig. 5). However, suspensions prepared with these smaller polyelectrolytes quickly lost their 
turbidity, suggesting that the nanoparticles were eventually breaking apart under these conditions and releasing 
the antimicrobial. The rate of degradation was also dependent on the DP of the PSS, with nanoparticles prepared 
at a 0.7 [n+/n−] ratio with PSSL recovering optical densities similar to that of the medium after 9 h, while up to 
12 h were required for nanoparticles prepared under the same conditions with PSSM (Fig. 5, left). This data was 
in agreement with the stability observed under simulated physiological conditions (Fig. 4), with formulations 
prepared with PSSH giving more stable nanoparticles that swelled less.
We then investigated the effect of PIC nanoparticles and their individual components on P. aeruginosa cul-
tures by monitoring as well their OD600 over time. This is a routine technique used in microbiology that correlates 
any increase in the turbidity of a sample to bacterial growth43. The growth of P. aeruginosa was not inhibited 
by the presence of the polymers (Fig. S6†, PSSL and PSSH shown as representative examples), but incubation 
with Pol-B at the concentrations found in PIC nanoparticles at 0.7 and 0.4 [n+/n−] ratios (87.5 and 50 µM, 
respectively) completely inhibited the growth of this bacterium for the duration of this experiment (Fig. S6†). To 
facilitate the visual comparison of these antimicrobial results, the OD600 values of P. aeruginosa cultures in the 
presence of PIC nanoparticles were normalised against the optical density observed one hour after the start of the 
experiment, when the initial increase in OD600 attributed to PIC nanoparticle swelling had stabilised (Fig. 6A,B), 
and plotted as a function of the polymer and formulation used at representative time points (Fig. 6C).
Decreasing the DP of PSS had a dramatic effect on the antimicrobial activity of the nanoparticles. Our previ-
ously reported particles could inhibit the growth of P. aeruginosa up to 14.5 h15, and similar effects were observed 
with the nanoparticles prepared with PSSH and PSSM at a 0.7 [n+/n−] ratio (Fig. 6A). However, PIC nanopar-
ticles prepared with the shortest polymer, PSSL, at the same [n+/n−] ratio showed a remarkable antimicrobial 
Figure 7. (A) Representative agar plates used to evaluate antimicrobial activity of PIC nanoparticles prepared 
from PSS and Pol-B. Lane 1: No dilution, lane 2: 102-fold dilution, lane 3: 104-fold dilution, and lane 4: 106-fold 
dilution. (B) CFU/mL of P. aeruginosa in the absence (control) and presence of PIC nanoparticles prepared from 
different PSS sources at different [n+/n−] ratios, calculated from the colonies found in the agar plates (one-way 
ANOVA, Tukey test, CI = 95%). ‘N/S’ = not significant. Error bars represent the standard deviation, n = 3.
www.nature.com/scientificreports/
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effect, with the turbidity at all times below that observed at the beginning of the experiment and no evidence of P. 
aeruginosa growth for the duration of the experiment (Fig. 6A,C). We believe this is a consequence of the lower 
stability of this formulation, that is able to maintain therapeutic levels of Pol-B throughout the duration of the 
experiment. Attempts to characterise the rate of release of Pol-B from these nanoparticles were compromised by 
the slow diffusion of this antimicrobial across the dialysis devices evaluated (Fig. S5), something we had observed 
for our previously reported nanoparticles15. Reducing the amount of antimicrobial had a detrimental effect on the 
antimicrobial activity of the nanoparticles, with formulations prepared with PSSL at a 0.4 [n+/n−] ratio showing 
signs of microbial growth after 20 hours of incubation (Fig. 6B and C). Nanoparticles prepared with PSSM and 
PSSH at this [n+/n−] ratio displayed an even weaker antimicrobial effect and after 14 hours the growth of the 
pathogen was evident again. Overall, nanoparticles containing PSSM and PSSH showed very similar antimicrobial 
activities regardless of their [n+/n−] ratio, and in general displayed no significant differences in the turbidity 
of bacterial cultures over time. These results are in agreement with the distinct physiological stability observed 
for these nanomaterials (Fig. 4), with PSSL at a 0.7 [n+/n−] ratio forming the least stable nanoparticles with the 
strongest antimicrobial activities across the range of DPs and [n+/n−] ratios tested.
Samples from these growth assays were collected after 24 hours of incubation and spotted on agar plates to 
quantify the number of viable bacteria remaining at this stage43. Several dilutions were spotted on agar plates 
to identify suitable conditions for colony counting. P. aeruginosa was able to grow under these conditions and 
we observed that PSSL (as a representative polymer) had no effect on this growth (Fig. 7A). Both concentra-
tions of Pol-B used to prepare the nanoparticles completely eradicated P. aeruginosa from the culture (control). 
Interestingly, all formulations displayed some degree of bactericidal effect, as evidenced by the decrease of approx-
imately two orders of magnitude in the number of viable bacterial colonies found for the least potent formula-
tions. These results were similar to those observed before for the 70 kDa PSS15, that showed also a decrease of two 
orders of magnitude in microbial viability, and in agreement with turbidity experiments (Fig. 6). Nanoparticles 
prepared at a 0.7 [n+/n−] ratio with the shortest polyelectrolyte, PSSL, were again those that showed the biggest 
antimicrobial effect. Remarkably, the number of viable colonies for this formulation was reduced more than six 
orders of magnitude (Fig. 7B), suggesting that these nanoparticles were over 10,000 times more efficient in killing 
P. aeruginosa than any of the other ones we have reported.
Conclusions
Here, we report the preparation and characterisation of Pol-B containing PIC nanoparticles using three dif-
ferent PSS selected across a wide range of degrees of polymerisation. We have assessed the physiological sta-
bility of these nanoparticles and their antimicrobial activity against P. aeruginosa, an opportunistic pathogen 
currently treated with Pol-B. Our results indicate that the antimicrobial activity of these nanoparticles can be 
significantly increased by tuning the degree of polymerisation of the polyelectrolyte component, in this case PSS. 
Nanoparticles prepared with the PSS with the smallest DP showed the highest antimicrobial activity. The antimi-
crobial activity of the nanoparticles prepared with PSS of this smallest degree of polymerisation was dependent 
of the [n+/n−] ratio, an effect not found in formulations prepared from longer polymers. Overall, tailoring the 
degree of polymerisation of PSS and the [n+/n−] ratio, we have been able to identify a PIC nanoparticle formu-
lation that shows a sustained inhibitory effect in the growth of P. aeruginosa and can reduce the number of viable 
colonies of this pathogen significantly more effectively than our previous reported formulation. We believe our 
results highlight the importance of selecting a correct polyelectrolyte and formulation to tune the stability and 
antimicrobial activity, and should be of value in the future development of these materials as a platform for the 
delivery of last-resort antimicrobials. Our efforts to further develop these nanomaterials, and tailor composition, 
formulation and stability for in vivo and ex vivo applications will be reported in due course.
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